TrialThe Lancet. Global health2017

Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation.

Anna Vassall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.